title: Development of a reservoir-type transdermal delivery system containing eucalyptus oil for tetramethylpyrazine.
abstract: The purpose of this study was to formulate a reservoir-type transdermal delivery system (TDS) for 2,3,5,6-tetramethylpyrazine (TMP) to enable the delivery of a sufficient dose through human skin to achieve an effective therapeutic plasma concentration. To improve the penetration of TMP in the reservoir-type TDS, several chemical penetration enhancers were investigated using in vitro rat dorsal skin permeation studies. Eucalyptus oil was found to enhance the permeation of TMP to the greatest extent, with the optimal concentration being 5% and the flux being 542.6 ± 49.7 μg/cm(2)/h, which was 4.5-fold greater than control with no enhancer (p < 0.01). The flux of the optimized reservoir-type TDS permeated through the human epidermis was 346.0 ± 27.7 μg/cm(2)/h. Based on the in vitro human skin permeation flux and the pharmacokinetics parameters observed, the clinical surface area of the TDS patch was predicted to be 20 cm(2). The in vivo study conducted in rabbits showed that the TMP TDS patch containing 5% eucalyptus oil had a more favorable pharmacokinetic profile, with a lower C(max) and prolonged T(max) and mean residence time than that observed with the oral administration of TMP. The TMP reservoir-type TDS was shown to be a promising alternative route to oral administration or intravenous infusion of TMP.
authors: Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education & PLA, School of Pharmacy, Fudan University, Shanghai, China. shenteng@fudan.edu.cn
authors: Teng
authors: T
authors: Shen
authors: Huinan
authors: H
authors: Xu
authors: Weiyu
authors: W
authors: Weng
authors: Jianfeng
authors: J
authors: Zhang
mesh_terms: D000328:Adult; D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods*; D005052:Eucalyptus / Q000378:metabolism*; D000078122:Eucalyptus Oil; D005260:Female; D006801:Humans; D039821:Monoterpenes / Q000008:administration & dosage / Q000378:metabolism; D009822:Oils, Volatile / Q000008:administration & dosage / Q000378:metabolism*; D009924:Organ Culture Techniques; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000378:metabolism*; D011719:Pyrazines / Q000008:administration & dosage / Q000378:metabolism*; D011817:Rabbits; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012869:Skin Absorption / Q000187:drug effects / Q000502:physiology*
chemical_list: C511306:Eucalyptus terpene oil; D039821:Monoterpenes; D009822:Oils, Volatile; D010975:Platelet Aggregation Inhibitors; D011719:Pyrazines; D000078122:Eucalyptus Oil; C017953:tetramethylpyrazine